Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
katerina-akassoglou
Press Release
Oct 31, 2019
$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer's Disease
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.
Read More
Press Release
Oct 8, 2019
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer's Disease
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego
Read More
Press Release
Feb 5, 2019
A New Culprit of Cognitive Decline in Alzheimer's Disease
Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments
Read More
Press Release
Oct 15, 2018
New Immunotherapy Targeting Blood-Clotting Protein Protects Multiple Sclerosis and Alzheimer's Disease Models
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks
Read More
Press Release
Nov 2, 2017
Blood-Clotting Protein Prevents Repair in the Brain
Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis
Read More
First
Prev
1
Next
Last
